Dr Ulrich Kissel
European QP Association (EQPA), KisselPharmaConsulting
Referierende
Dr Fatima Bicane
Pharma Deutschland
GMP-RELATED CHANGES AND AMENDMENTS IN THE NEW REGULATION AND DIRECTIVE
Zielgruppe
- Professionals involved in GMP-relevant activities within the pharmaceutical Industry
- Personnel responsible for preparing for or implementing regulatory updates in their organisations
- Anyone who wants an overview of the expected GMP-related changes proposed in the revision of EU Medicines Legislation
Zielsetzung
On 10th December 2025 co-legislators reached a provisional agreement on revamping the EU’s pharmaceutical policy framework, to boost competitiveness, innovation and security of supply.
The reform aims to improve availability, accessibility and affordability of medicines, while promoting higher environmental standards and increasing competitiveness of the pharmaceutical industry in the EU. Key elements include reducing administrative burdens, promoting innovation and competitiveness, addressing shortages, ensuring environmental sustainability and tackling antimicrobial resistance.
There are also GMP-relevant changes, which will be discussed in this Live Online Session.
The reform aims to improve availability, accessibility and affordability of medicines, while promoting higher environmental standards and increasing competitiveness of the pharmaceutical industry in the EU. Key elements include reducing administrative burdens, promoting innovation and competitiveness, addressing shortages, ensuring environmental sustainability and tackling antimicrobial resistance.
There are also GMP-relevant changes, which will be discussed in this Live Online Session.
Programm
Status and Overview of the Revision of the Pharmaceutical Legislation in the EU
- Part I: Legal Instrument and legislative process
- Part II: New Directive of the European parliament and the council on the Union code relating to medicinal products for human use
- Part III: New Regulation of the European parliament and the council laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency
GMP-relevant Consequences from Directive and Regulation
- The manufacturer, the QP and the new directive 2023/192
- The manufacturer, the QP and the new regulation 2023/193
- Discussion and observations
- The QP and the new Annex III to directive 2023/192
- ECA-EQPA comments
- Early and expected impacts on GMP rules and applicability
- Conclusion
Weitere Informationen
To participate in an on demand training course or webinar, you do not need any software. The recordings are made available via a streaming server. In general, the recording is provided in MP4 format, which any PC (Microsoft Windows, Apple IOS) or tablet can easily display.
Timing and Duration:
When you register for the on demand Training course or webinar you can decide at what date you want to follow the training course online. For a 1-day training course you will have 2 days in which the stream is available (for 2-day training course 3 days and for a 3-day training course 4 days). Within in this timeframe you can start & stop the stream according to your needs.
In time before the scheduled date (your desired date) you will receive an e-mail from us with a link for direct participation as well as your log-in data.
Please be aware: The recording does not include the Q & A sessions.
Training Course Documentation and Certificate:
The presentation will be made available as PDF-files via download during the online training course. After the successful completion of the online training, you are able to download the certificate of attendance.
Timing and Duration:
When you register for the on demand Training course or webinar you can decide at what date you want to follow the training course online. For a 1-day training course you will have 2 days in which the stream is available (for 2-day training course 3 days and for a 3-day training course 4 days). Within in this timeframe you can start & stop the stream according to your needs.
In time before the scheduled date (your desired date) you will receive an e-mail from us with a link for direct participation as well as your log-in data.
Please be aware: The recording does not include the Q & A sessions.
Training Course Documentation and Certificate:
The presentation will be made available as PDF-files via download during the online training course. After the successful completion of the online training, you are able to download the certificate of attendance.
Fees (per delegate, plus VAT)
ECA Members EUR 590
APIC Members EUR 640
Non-ECA Members EUR 690
EU GMP Inspectorates EUR 590
The conference fee is payable in advance after receipt of invoice.
The Registration does not include ECA Membership.
ECA Members EUR 590
APIC Members EUR 640
Non-ECA Members EUR 690
EU GMP Inspectorates EUR 590
The conference fee is payable in advance after receipt of invoice.
The Registration does not include ECA Membership.
Conference language
The official conference language will be English.
Contacts
Questions regarding content:
Mr Wolfgang Schmitt, +49 6221 84 44-39, w.schmitt@concept-heidelberg.de
The official conference language will be English.
Contacts
Questions regarding content:
Mr Wolfgang Schmitt, +49 6221 84 44-39, w.schmitt@concept-heidelberg.de
Questions regarding organisation:
Ms Manuela Luckhaupt, +49 6221 84 44-66, luckhaupt@concept-heidelberg.de
Recording from 17 March 2026
Duration of the recording: approx. 3h 35m
Teilnahmegebühr
| ECA-Member*: | € 590,- |
| Regular Fee*: | € 690,- |
| EU/GMP Inspectorates*: | € 590,- |
| APIC Member Discount*: | € 640,- |
Alle Preise zzgl. MwSt. Wichtige Hinweise zur Umsatzsteuer.
* auch unkompliziert per Kreditkarte bezahlbar
Aufzeichnung/weitere Termine nicht verfügbar
Aufzeichnung/weitere Termine nicht verfügbar
Haben Sie noch Fragen?
Wir stehen Ihnen für weitere Auskünfte gerne zur Verfügung.
E-Mail: info@concept-heidelberg.de
Teilnehmerstimmen
Teilnehmerstimmen - das sagen andere über unsere Seminare:
